Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androxal Extension Study in Secondary Hypogonadism
NCT01386567Phase 2Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- Jul 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enclomiphene in secondary hypogonadism (HH), sponsored by Repros Therapeutics Inc.. Started Jul 2011; status: completed.
02
Drugs
enclomiphene
03
Conditions
secondary hypogonadism (HH)
Beyond the preview
Go deeper on NCT01386567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386567.